High mobility group box1 inhibitor glycyrrhizic acid attenuates kidney injury in streptozotocin-induced diabetic rats
INGREDIENTES* : Maz y/o avena y/o cebada y/o trigo, pastas de oleaginosas, aceite vegetal y/o melaza de caa, salvado de trigo y/o pulido de arroz y/o salvado de arroz y/o granos secos de destilera y/o cascarilla de soya y/o de avena y/o alfalfa deshidratada, linaza, carbonato de calcio, ortofosfato de calcio, sal comn (cloruro de sodio) y/o bicarbonato de sodio, bentonita y/o caoln y/o aluminosilicatos y/o lignosulfonatos, manano oligosacridos y -glucanos de levadura desactivada (Pichia guilliermondii) y/o levaduras deshidratadas (Saccharomyces cerevisiae boulardii 4106 UFC/g)
It is a synthetic peptide modelled on residues 176191 of the C-terminal end of human growth hormone, modified by adding a tyrosine residue to the N-terminus to improve stability
Dietary intake is modest estimated at 100-150 mg/day from fruits, vegetables, and meats and much of this is broken down by digestive enzymes (gamma-glutamyltranspeptidase and dipeptidases) in the intestinal lumen before absorption [1][2]
